Page 120 AG115
P. 120
therapy. III. Reduction in venous thrombosis and
pulmonary embolism by antiplatelet prophylaxis
among surgical and medical patients. Brit Med J
308:235–246, 1994.
- Antithrombotic Trialists’ Collaboration (2002).
Collaborative meta-analysis of randomised trials
of antiplatelet therapy for prevention of death,
myocardial infarction, and stroke in high risk
patients. Brit Med J 324:71-86, 2002.
- Black KL, Culp B, Madison D, et al The pro-
tective effect of dietary fish oil on focal cere-
bral infarction. Prostaglandins Med 3, 257-268,
1979.
- Budowskj ., Trostler N, Lupo M, et al Effect of
linseed oil ingestion on plasma lipid fatty acid
composition and platelet aggregability in healthy
volunteers. Nutr Res 4:343-346, 1984.
- Burr ML; Fehily AM; Rogers S, et al Diet and
reinfarction trial (DART): design, recruitment,
and compliance. Eur Heart J 10(6):558-567,
1989.
- Collaborative overview of randomised trials of
antiplatelet therapy: prevention of death, myo-
cardial infarction, and stroke by prolonged anti-
platelet therapy in various categories of patients.
Brit Med J 308:81-106, 1994.
- Culp BR, Lands WEM, Lucchesi BR, et al The
effect of dietary supplementation of fish oil on
experimental myocardial infarction. Prostaglan-
dins 20:1021-1031, 1980.
- de Logeril M, et al, The Final Report of the Lyon
Diet Heart Study. Circulation 99:779-785, 1999.
- Dolecek TA, Granditis G. Dietary polyunsatu-
rated fatty acids and mortality in the Multiple
Risk Factor Intervention Trial (MRFIT). World
Rev Nutr Diet 66: 205216, 1991. Dyerberg J.
Platelet-vessel wall interactions. Philos Trans R
Soc London Ser B 294:373-381, 1981.
- Dyerberg J, Bang HO. Dietary fat and thrombo-
sis. Lancet 1:152, 1978.
- Dyerberg J, Bang HO.. Lipid metabolism, athe-
rogenesis and haemostasis in Eskimos: The
role of the prostaglandin-3 family. Haemostasis
8:227-233, l979a.
- Dyerberg J, Bang HO. Haemostatic function and
platelet polyunsaturated fat acids in Eskimos.
Lancet 2:433-435, 1979b.
- Dyerberg J, Bang HO, Stoffersen E, et al Eico-
sapentaenoic acid and prevention of thrombosis
and atherosclerosis. Lancet 2:117-119, 1978.
- GISSI-Prevenzioni Group. Dietary supplemen-
tation with n-3 polyunsaturated fatty acids and
vitamin E after myocardial infarction: results of
the GISSI-Prevenzione trial. Lancet 354:447-
455, 1999, plus an editorial by M. Brown, Lan-
cet 1999; 354:441-442, 1999.
- Goodnight SH Jr, Harris WS, Connor W. The
effects of dietary w-3 fatty acids on platelet
composition and function in man: A prospective,
controlled study. Blood 58(5):880-885, 1981.
- Hamazaki, T., Hirai, A., Terano, et al Effects of
orally administered ethyl ester of eicosapentae-
noic acid (EPA; C20:5, w-3) on PGI2-like subs-
tance production by rat aorta. Prostaglandins
23:557-567, 1982.
- Hamberg M, Svensson J, Wakabayashi T, et al
Isolation and structure of two prostaglandin
endoperoxides that cause platelet aggregation.
Proc Natl Acad Sci USA1:345-349, 1974a.
- Hamberg M, SvenssonJ, Samuelsson B. Pros-
taglandin endoperoxides. A new concept con-
cerning the mode of action and release of pros-
taglandins. Proc Natl Acad Sci USA 1:3824-
3828, 1974b.
- Hamberg M, Svensson J, Samuelsson B. Throm-
boxanes: A new group of biologically active
compounds derived from prostaglandin endope-
roxides. Proc Natl Acad Sci USA 72:2994- 2998,
1975.
- Hay CRM, Durber AP, Saynor R. Effect of fish
oil on platelet kinetics in patients with ischaemic
heart disease. Lancet 1:1269-1272, 1082, 1982.
- Hennekens CH. (2002) Update on aspirin in
the treatment and prevention of cardiovascu-
lar disease. Am J Manag Care. 22 (Suppl):
S691-S700, 2002.
- Hirai A, Hamazaki T, Terano T, et al Eicosapen-
taenoic acid and platelet function in Japanese.
Lancet 2:1132-1133, 1980.
- Hwang DH, Carrol AE. Decreased formation
of prostaglandin derived from arachidonic acid
by dietary linolenate in rats. Am J Clin Nutr
33:590-597, 1980.
- Jakubowski JA, Ardlie NG, Morgan FJ, et al
(1982). Further observations on the effects of
dietary fatty acid composition on platelet reac-
tivity and blood coagulation in man and the
influence of methodology on findings. Atheros-
clerosis 41:285-294, 1982.
- Knapp HR, Reilly IA, Alessandrini P, et al In
vivo indexes of platelet and vascular function
during fish-oil administration in patients with
atherosclerosis. N Engl J Med 314:937-942,
1986.
- Kobayashi S, Hirai A, Terano T, et al Reduction
in blood viscosity by eicosapentaenoic acid.
Lancet 2:197, 1981.
- Lands WEM, LeTellier PR, Rome LH, et al Inhi-
bition of prostaglandin biosynthesis. Adv Bios-
ciences 9:15-28, 1973.
- Lands WEM, Culp BR, Hirai A, et al (1985).
Relationship of thromboxane generation to the
aggregation of platelets from humans: Effects of
eicosapentaenoic acid. Prostaglandins 30:819-
825, 1985.
- Lea EJA, Jones SP, Hamilton DV. (1982). The
fatty acids of erythrocytes of myocardial infarc-
tion patients. Atherosclerosis 41, 363-369, 1982.
- Lorenz R, Spengler U, Fischer S, et al (1983).
Platelet function, thromboxane formation and
blood pressure control during supplementation
of the western diet with cod liver oil. Circulation
67, 504-511, 1983.
- Moncada S, Vane JR. Prostacyclin: Its
biosynthesis, actions and clinical potential. Phi-
los Trans R Soc London Ser B 294:305-329,
1981.
- Moncada S, Gryglewski R, Bunting S, et al An
enzyme isolated from arteries transforms prosta-
glandin endoperoxides to an unstable substance
that inhibits platelet aggregation. Nature 263,
663-665, 1976.
- Morita I, Komeshinia N, Takahashi R, et al.
(1984). A proposed method for exploring antiag-
gregatory effects of eicosapentaenoic acid in the
rat. Prostaglandins, Leukotrienes Med 14:123-
129, 1984.
- Mortensen JZ, Schmidt EB, Nielsen AH, et al.
(1983). The effect of n-6 and n-3 polyunsatura-
ted fatty acids on hemostasis, blood lipids and
blood pressure. Thromb Haemosrasjs 50:543-
546, 1983.
- MRC General Practice Research Framework.
Thrombosis prevention trial: randomised trial of
low-intensity oral anticoagulation with warfarin
and low-dose aspirin in the primary prevention
of ischemic heart disease in men at increased
risk. Lancet 351:233-241, 1998.
- Nagakawa Y, Orimo H., Harasawa M, et al
Effect of elcosapentaenojc acid on the platelet
aggregation and composition of fatty acid in
man. Atherosclerosis 47:71-75, 1983.
- Natvig H, Borchgrevink CF, Dedichen J, et al
(1968) A controlled trial of the effect of linolenic
acid on incidence of coronary heart disease. The
Norwegian vegetable oil experiment of 1965-66.
Scand J Clin Lab Invest Suppl 105:1-20, 1968.
- Needleman P, Whitaker MG, Wyche A, et al
Manipulation of platelet aggregation by prosta-
glaridins and their fatty acid precursors: Phar-
macological basis for a therapeutic approach.
Prostaglandins 19:165-180, 1980..
- Owren PA. Coronary thrombosis. Its mechanism
and possible prevention by linolenic acid. Ann
Intern Med 63:167-184, 1965a.
- Owren PA. Linolenic acid and coronary throm-
bosis. Ann Intern Med 63:1160, 1965b.
- Owren PA, Hellem AJ, Odegaard A. Linolenic
acid for the prevention of thrombosis and myo-
cardial infarction. Lancet 2:975-979, 1964.
- Park Y, Schoene N, Harris W. Mean platelet
volume as an indicator of platelet activation:
methodological issues. Platelets 13:301-306,
2002.
- Patrono C, Bachmann F, Baigent C. Expert
Consensus Document on the use of antiplatelet
agents: The Task Force on the Use of Antiplate-
let Agents in Patients with Atherosclerotic Car-
diovascular Disease of the European Society of
Cardiology. Eur Heart J 25:166-181, 2004.
- Physicians Health Study Research Group; Stee-
ring Committee. Final report on the aspirin com-
ponent of the ongoing Physicians’ Health Study.
N Engl J Med 321:129-135, 1989.
- Raz A, Minkes MS, Needleman P. Structural
determinants for platelet aggregation and vaso-
constriction. Biochim Biophys Acta 488:305-
311, 1977.
- Ridker PM, Manson JE, Buring JE, et al The
effect of chronic platelet inhibition with lowdose
aspirin on atherosclerotic progression and acute
thrombosis: clinical evidence from the Physi-
cians Health Study. Am Heart J 122:1588-1592,
1991.
- Ross R, Glomset JA. The pathogenesis of athe-
rosclerosis I. N EngI J Med 295:369-377, 1976.
- Ross R, Glomset JA. The pathogenesis of athe-
rosclerosis. II. N Engl J. Med 295, 420-425,
1976.
- Sanders TA. Dietary fat and postprandial lipids.
Curr Atheroscler Rep 5(6):445-451, 2003.
- Sanders TA, Berry SE, Miller GJ. Influence of
triacylglycerol structure on the postprandial res-
ponse of factor VII to stearic acid-rich fats. Am J
A&G 115
• Tomo XXIX • Vol. 2 • 258-267 • (2019)
266
· S A l U d Y N UTRICIÓN ·
pulmonary embolism by antiplatelet prophylaxis
among surgical and medical patients. Brit Med J
308:235–246, 1994.
- Antithrombotic Trialists’ Collaboration (2002).
Collaborative meta-analysis of randomised trials
of antiplatelet therapy for prevention of death,
myocardial infarction, and stroke in high risk
patients. Brit Med J 324:71-86, 2002.
- Black KL, Culp B, Madison D, et al The pro-
tective effect of dietary fish oil on focal cere-
bral infarction. Prostaglandins Med 3, 257-268,
1979.
- Budowskj ., Trostler N, Lupo M, et al Effect of
linseed oil ingestion on plasma lipid fatty acid
composition and platelet aggregability in healthy
volunteers. Nutr Res 4:343-346, 1984.
- Burr ML; Fehily AM; Rogers S, et al Diet and
reinfarction trial (DART): design, recruitment,
and compliance. Eur Heart J 10(6):558-567,
1989.
- Collaborative overview of randomised trials of
antiplatelet therapy: prevention of death, myo-
cardial infarction, and stroke by prolonged anti-
platelet therapy in various categories of patients.
Brit Med J 308:81-106, 1994.
- Culp BR, Lands WEM, Lucchesi BR, et al The
effect of dietary supplementation of fish oil on
experimental myocardial infarction. Prostaglan-
dins 20:1021-1031, 1980.
- de Logeril M, et al, The Final Report of the Lyon
Diet Heart Study. Circulation 99:779-785, 1999.
- Dolecek TA, Granditis G. Dietary polyunsatu-
rated fatty acids and mortality in the Multiple
Risk Factor Intervention Trial (MRFIT). World
Rev Nutr Diet 66: 205216, 1991. Dyerberg J.
Platelet-vessel wall interactions. Philos Trans R
Soc London Ser B 294:373-381, 1981.
- Dyerberg J, Bang HO. Dietary fat and thrombo-
sis. Lancet 1:152, 1978.
- Dyerberg J, Bang HO.. Lipid metabolism, athe-
rogenesis and haemostasis in Eskimos: The
role of the prostaglandin-3 family. Haemostasis
8:227-233, l979a.
- Dyerberg J, Bang HO. Haemostatic function and
platelet polyunsaturated fat acids in Eskimos.
Lancet 2:433-435, 1979b.
- Dyerberg J, Bang HO, Stoffersen E, et al Eico-
sapentaenoic acid and prevention of thrombosis
and atherosclerosis. Lancet 2:117-119, 1978.
- GISSI-Prevenzioni Group. Dietary supplemen-
tation with n-3 polyunsaturated fatty acids and
vitamin E after myocardial infarction: results of
the GISSI-Prevenzione trial. Lancet 354:447-
455, 1999, plus an editorial by M. Brown, Lan-
cet 1999; 354:441-442, 1999.
- Goodnight SH Jr, Harris WS, Connor W. The
effects of dietary w-3 fatty acids on platelet
composition and function in man: A prospective,
controlled study. Blood 58(5):880-885, 1981.
- Hamazaki, T., Hirai, A., Terano, et al Effects of
orally administered ethyl ester of eicosapentae-
noic acid (EPA; C20:5, w-3) on PGI2-like subs-
tance production by rat aorta. Prostaglandins
23:557-567, 1982.
- Hamberg M, Svensson J, Wakabayashi T, et al
Isolation and structure of two prostaglandin
endoperoxides that cause platelet aggregation.
Proc Natl Acad Sci USA1:345-349, 1974a.
- Hamberg M, SvenssonJ, Samuelsson B. Pros-
taglandin endoperoxides. A new concept con-
cerning the mode of action and release of pros-
taglandins. Proc Natl Acad Sci USA 1:3824-
3828, 1974b.
- Hamberg M, Svensson J, Samuelsson B. Throm-
boxanes: A new group of biologically active
compounds derived from prostaglandin endope-
roxides. Proc Natl Acad Sci USA 72:2994- 2998,
1975.
- Hay CRM, Durber AP, Saynor R. Effect of fish
oil on platelet kinetics in patients with ischaemic
heart disease. Lancet 1:1269-1272, 1082, 1982.
- Hennekens CH. (2002) Update on aspirin in
the treatment and prevention of cardiovascu-
lar disease. Am J Manag Care. 22 (Suppl):
S691-S700, 2002.
- Hirai A, Hamazaki T, Terano T, et al Eicosapen-
taenoic acid and platelet function in Japanese.
Lancet 2:1132-1133, 1980.
- Hwang DH, Carrol AE. Decreased formation
of prostaglandin derived from arachidonic acid
by dietary linolenate in rats. Am J Clin Nutr
33:590-597, 1980.
- Jakubowski JA, Ardlie NG, Morgan FJ, et al
(1982). Further observations on the effects of
dietary fatty acid composition on platelet reac-
tivity and blood coagulation in man and the
influence of methodology on findings. Atheros-
clerosis 41:285-294, 1982.
- Knapp HR, Reilly IA, Alessandrini P, et al In
vivo indexes of platelet and vascular function
during fish-oil administration in patients with
atherosclerosis. N Engl J Med 314:937-942,
1986.
- Kobayashi S, Hirai A, Terano T, et al Reduction
in blood viscosity by eicosapentaenoic acid.
Lancet 2:197, 1981.
- Lands WEM, LeTellier PR, Rome LH, et al Inhi-
bition of prostaglandin biosynthesis. Adv Bios-
ciences 9:15-28, 1973.
- Lands WEM, Culp BR, Hirai A, et al (1985).
Relationship of thromboxane generation to the
aggregation of platelets from humans: Effects of
eicosapentaenoic acid. Prostaglandins 30:819-
825, 1985.
- Lea EJA, Jones SP, Hamilton DV. (1982). The
fatty acids of erythrocytes of myocardial infarc-
tion patients. Atherosclerosis 41, 363-369, 1982.
- Lorenz R, Spengler U, Fischer S, et al (1983).
Platelet function, thromboxane formation and
blood pressure control during supplementation
of the western diet with cod liver oil. Circulation
67, 504-511, 1983.
- Moncada S, Vane JR. Prostacyclin: Its
biosynthesis, actions and clinical potential. Phi-
los Trans R Soc London Ser B 294:305-329,
1981.
- Moncada S, Gryglewski R, Bunting S, et al An
enzyme isolated from arteries transforms prosta-
glandin endoperoxides to an unstable substance
that inhibits platelet aggregation. Nature 263,
663-665, 1976.
- Morita I, Komeshinia N, Takahashi R, et al.
(1984). A proposed method for exploring antiag-
gregatory effects of eicosapentaenoic acid in the
rat. Prostaglandins, Leukotrienes Med 14:123-
129, 1984.
- Mortensen JZ, Schmidt EB, Nielsen AH, et al.
(1983). The effect of n-6 and n-3 polyunsatura-
ted fatty acids on hemostasis, blood lipids and
blood pressure. Thromb Haemosrasjs 50:543-
546, 1983.
- MRC General Practice Research Framework.
Thrombosis prevention trial: randomised trial of
low-intensity oral anticoagulation with warfarin
and low-dose aspirin in the primary prevention
of ischemic heart disease in men at increased
risk. Lancet 351:233-241, 1998.
- Nagakawa Y, Orimo H., Harasawa M, et al
Effect of elcosapentaenojc acid on the platelet
aggregation and composition of fatty acid in
man. Atherosclerosis 47:71-75, 1983.
- Natvig H, Borchgrevink CF, Dedichen J, et al
(1968) A controlled trial of the effect of linolenic
acid on incidence of coronary heart disease. The
Norwegian vegetable oil experiment of 1965-66.
Scand J Clin Lab Invest Suppl 105:1-20, 1968.
- Needleman P, Whitaker MG, Wyche A, et al
Manipulation of platelet aggregation by prosta-
glaridins and their fatty acid precursors: Phar-
macological basis for a therapeutic approach.
Prostaglandins 19:165-180, 1980..
- Owren PA. Coronary thrombosis. Its mechanism
and possible prevention by linolenic acid. Ann
Intern Med 63:167-184, 1965a.
- Owren PA. Linolenic acid and coronary throm-
bosis. Ann Intern Med 63:1160, 1965b.
- Owren PA, Hellem AJ, Odegaard A. Linolenic
acid for the prevention of thrombosis and myo-
cardial infarction. Lancet 2:975-979, 1964.
- Park Y, Schoene N, Harris W. Mean platelet
volume as an indicator of platelet activation:
methodological issues. Platelets 13:301-306,
2002.
- Patrono C, Bachmann F, Baigent C. Expert
Consensus Document on the use of antiplatelet
agents: The Task Force on the Use of Antiplate-
let Agents in Patients with Atherosclerotic Car-
diovascular Disease of the European Society of
Cardiology. Eur Heart J 25:166-181, 2004.
- Physicians Health Study Research Group; Stee-
ring Committee. Final report on the aspirin com-
ponent of the ongoing Physicians’ Health Study.
N Engl J Med 321:129-135, 1989.
- Raz A, Minkes MS, Needleman P. Structural
determinants for platelet aggregation and vaso-
constriction. Biochim Biophys Acta 488:305-
311, 1977.
- Ridker PM, Manson JE, Buring JE, et al The
effect of chronic platelet inhibition with lowdose
aspirin on atherosclerotic progression and acute
thrombosis: clinical evidence from the Physi-
cians Health Study. Am Heart J 122:1588-1592,
1991.
- Ross R, Glomset JA. The pathogenesis of athe-
rosclerosis I. N EngI J Med 295:369-377, 1976.
- Ross R, Glomset JA. The pathogenesis of athe-
rosclerosis. II. N Engl J. Med 295, 420-425,
1976.
- Sanders TA. Dietary fat and postprandial lipids.
Curr Atheroscler Rep 5(6):445-451, 2003.
- Sanders TA, Berry SE, Miller GJ. Influence of
triacylglycerol structure on the postprandial res-
ponse of factor VII to stearic acid-rich fats. Am J
A&G 115
• Tomo XXIX • Vol. 2 • 258-267 • (2019)
266
· S A l U d Y N UTRICIÓN ·
